Journal of Jilin University(Medicine Edition) ›› 2020, Vol. 46 ›› Issue (6): 1315-1323.doi: 10.13481/j.1671-587x.20200633
• Imageology • Previous Articles Next Articles
Kunying ZHU1,Shijie GUO2,Ruosen YUAN3,Dong PAN3,Chun ZHANG3,Xiaoxu CHEN3,Yanming YI3,Yang YANG3,Baisong ZHENG1(
),Chunlai JIANG4(
)
Received:2020-05-19
Online:2020-11-28
Published:2022-08-24
Contact:
Baisong ZHENG,Chunlai JIANG
E-mail:zhengbs@jlu.edu.cn;jiangcl@jlu.edu.cn
CLC Number:
Kunying ZHU,Shijie GUO,Ruosen YUAN,Dong PAN,Chun ZHANG,Xiaoxu CHEN,Yanming YI,Yang YANG,Baisong ZHENG,Chunlai JIANG. Establishment and validation of double antibody sandwich ELISA for determination of varicella zoster virus glycoprotein level[J].Journal of Jilin University(Medicine Edition), 2020, 46(6): 1315-1323.
Tab.2
A(450) values identified by checkerboard titration with VZV-mAb-03 and VZV-mAb-HRP-02"
| VZV?mAb?HRP-02 | A(450) value | |||
|---|---|---|---|---|
| 1∶2 500 | 1∶5 000 | 1∶7 500 | 1∶10 000 | |
| 1∶2 000(P) | 2.714±0.012 | 2.510±0.017 | 2.137±0.006 | 1.842±0.003 |
| 1∶2 000(N) | 0.126±0.004 | 0.114±0.004 | 0.102±0.005 | 0.096±0.004 |
| 1∶4 000(P) | 1.913±0.002 | 1.613±0.008 | 1.305±0.015 | 0.578±0.004 |
| 1∶4 000(N) | 0.082±0.006 | 0.075±0.004 | 0.082±0.005 | 0.064±0.004 |
| 1∶6 000(P) | 1.673±0.006 | 1.155±0.004 | 1.059±0.008 | 0.479±0.004 |
| 1∶6 000(N) | 0.066±0.003 | 0.062±0.004 | 0.064±0.002 | 0.053±0.001 |
| 1∶8 000(P) | 1.230±0.005 | 0.915±0.011 | 0.756±0.007 | 0.406±0.004 |
| 1∶8 000(N) | 0.063±0.002 | 0.064±0.005 | 0.069±0.004 | 0.067±0.004 |
Tab.4
Screening results of blocking conditions and blocking solutions"
| Blocking solution | 37 ℃,1 h | 37 ℃,2 h | ||||
|---|---|---|---|---|---|---|
| Positive A(450) value | Negative A(450) value | P/N ratio | Positive A(450) value | Negative A(450) value | P/N ratio | |
| 1%BSA | 0.763±0.044 | 0.135±0.008 | 5.63 | 1.145±0.001 | 0.111±0.014 | 10.32 |
| 3%BSA | 0.582±0.020 | 0.111±0.004 | 5.22 | 0.915±0.002 | 0.102±0.002 | 8.97 |
| 5% Nonfat dry milk | 0.332±0.016 | 0.080±0.014 | 4.14 | 0.465±0.001 | 0.066±0.010 | 6.99 |
| 10% Newborn bovine serum | 0.438±0.015 | 0.052±0.002 | 8.42 | 0.526±0.002 | 0.058±0.001 | 9.00 |
Tab. 5
A(450) values and P/N ratios of different color reaction time"
| Chromogenic time | Positive A(450) value | P difference between adjacent 5 min | Negative A(450) value | N difference between adjacent 5 min | P/N ratio | P/N difference between adjacent 5 min |
|---|---|---|---|---|---|---|
| 5 min | 1.071 5 | 0.497 | 0.068 5 | 0.005 | 15.64 | 99.4 |
| 10 min | 1.568 5 | 0.374 | 0.073 5 | 0.014 | 21.34 | 26.7 |
| 15 min | 1.942 5 | 0.324 | 0.087 0 | 0.008 | 22.33 | 40.5 |
| 20 min | 2.266 5 | 0.255 | 0.095 5 | 0.006 | 23.73 | 42.5 |
| 25 min | 2.522 0 | 0.187 | 0.101 5 | 0.025 | 24.85 | 7.5 |
| 30 min | 2.709 0 | — | 0.127 0 | — | 21.33 | — |
| “-”No data. |
Tab. 6
In-batch verification results of accuracies and precisions"
| Theoretical titer (PFU·mL-1) | Sample 1(n=4) | Sample 2(n=4) | Sample 3(n=4) | |||
|---|---|---|---|---|---|---|
Recovery rate (η/%) | CV (η/%) | Recovery rate (η/%) | CV (η/%) | Recovery rate(η/%) | CV (η/%) | |
| 506 | 89.2 | 10.2 | 95.3 | 4.4 | 98.3 | 5.5 |
| 1 013 | 104.7 | 4.1 | 100.8 | 1.5 | 102.8 | 5.0 |
| 1 520 | 115.7 | 3.1 | 100.9 | 3.8 | 101.8 | 3.5 |
| 2 027 | 112.0 | 6.5 | 106.4 | 3.5 | 116.8 | 1.1 |
| 2 534 | 82.2 | 7.8 | 93.0 | 3.4 | 88.0 | 4.3 |
| Average value | 100.7±13.0 | 5.4±1.9 | 99.3±4.7 | 3.1±0.9 | 101.5±9.3 | 3.5±1.5 |
Tab.7
Batch to batch verification results of accuracies and precisions"
| Theoretical titer(PFU·mL-1) | Inplate(n=8)(η/%) | Inter?plate(n=3) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test 1 | Test 2 | Test 3 | |||||||||||
| CV(η/%) | Recovery rate(η/%) | CV(η/%) | Recovery rate(η/%) | CV(η/%) | Recovery rate(η/%) | CV(η/%) | Recovery rate(η/%) | ||||||
| 506 | 6.1 | 85.5 | 4.8 | 91.9 | 8.0 | 95.9 | 4.7 | 91.1 | |||||
| 1 013 | 6.5 | 85.6 | 6.6 | 106.4 | 6.6 | 102.4 | 9.2 | 98.2 | |||||
| 1 520 | 10.1 | 84.9 | 4.2 | 115.6 | 6.8 | 106.7 | 12.6 | 102.4 | |||||
| 2 027 | 12.3 | 90.1 | 11.1 | 118.6 | 6.8 | 116.9 | 12.1 | 108.5 | |||||
| 2 534 | 15.4 | 80.5 | 17.4 | 81.7 | 11.2 | 109.8 | 14.9 | 90.6 | |||||
| Average value | 10.0±3.5 | 85.3±3.0 | 8.8±4.9 | 102.8±14.0 | 7.9±1.7 | 106.3±7.0 | 10.7±3.5 | 98.2±6.8 | |||||
| 1 | ARVIN A M. Varicella-zoster virus [ J ]. J Clin Microbiol Rev, 1996, 9(3):361-381. |
| 2 | ZERBONI L, SEN N, OLIVER S L, et al. Molecular mechanisms of varicella zoster virus pathogenesis[J]. Nat Rev Microbiol, 2014, 12(3): 197-210. |
| 3 | PLOTKIN S A, ORENSTEIN W A, OFFIT P A. Vaccine [M]. 5th ed. Singapore:Elsevier,2011. |
| 4 | 权娅茹, 李长贵. 水痘和带状疱疹及其疫苗[J]. 中国食品药品监管, 2019(4): 87-91. |
| 5 | KENNEDY P G, GRANER M W, GUNAYDIN D, et al. Varicella-Zoster Virus infected human neurons are resistant to apoptosis[J]. J Neurovirol, 2020, 26(3): 330-337. |
| 6 | QUINLIVAN M L, AYRES K L, KELLY P J, et al. Persistence of varicella-zoster virus viraemia in patients with herpes zoster[J]. J Clin Virol, 2011, 50(2): 130-135. |
| 7 | DAVID W W, JUDITH B. Herpes zoster [J]. J Clin Rev, 2007, 334:1211-1215. |
| 8 | WEINBERG A, LAZAR A A, ZERBE G O, et al. Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses[J]. J Infect Dis, 2010, 201(7): 1024-1030. |
| 9 | ARNOU R, FIQUET A, THOMAS S, et al. Immunogenicity and safety of ZOSTAVAX® approaching expiry potency in individuals aged ≥50 years[J]. Hum Vaccines, 2011, 7(10): 1060-1065. |
| 10 | 王军志. 疫苗的质量控制与评价[M]. 北京:人民卫生出版社, 2013:654-670. |
| 11 | Varicella and herpes zoster vaccines: WHO position paper, June 2014[J]. Wkly Epidemiol Rec, 2014, 89(25): 265-287. |
| 12 | 国家药典编辑委员会. 中华人民共和国药典(三部)[M]. 北京:中国医药科技出版社,2015:178-180. |
| 13 | RUSSELL M S, LI C G, LAROCQUE L, et al. Rapid and accurate determination of the potency of varicella vaccine by quantitative polymerase chain reaction[J].Vaccine,2011, 29(47): 8490-8495. |
| 14 | 赵 铠, 章以浩, 李河民. 医学生物制品学 [M].2版.北京:人民卫生出版社,2007:790-791. |
| 15 | LIU J, ZHU R, YE X Z, et al. A monoclonal antibody-based VZV glycoprotein E quantitative assay and its application on antigen quantitation in VZV vaccine[J]. Appl Microbiol Biotechnol, 2015, 99(11): 4845-4853. |
| 16 | 周 钦, 贾继宗, 刘 剑, 等. 水痘-带状疱疹病毒抗原的ELISA定量检测方法的建立 [ J ]. 中国免疫学杂志, 2013, 29(5):542-545, 552. |
| 17 | 柳忠辉, 邵启祥. 常用免疫学实验技术 [ M ]. 北京:高等教育出版社, 2013:10-15. |
| 18 | 贾继宗, 韩金乐, 杨 亮, 等. 柯萨奇病毒A组16型抗原的ELISA定量检测方法建立 [J]. 中国免疫学杂志, 2012, 28(4):351-354. |
| 19 | 张玲玲, 包正琦, 张光磊, 等. 破伤风抗毒素间接ELISA检测方法的建立及应用[J]. 中国生物制品学杂志, 2019, 32(4): 454-457, 461. |
| 20 | COUNCIL FOR HARMONIZATION INTERNATIONAL. New ICH M10 guideline in development on bioanalytical method validation [EB/OL].(2016-10-20)[2020-5-6]. . |
| 21 | 刘旻翾, 丁光明, 付钰广, 等. 猪伪狂犬病毒间接ELISA抗体检测方法的建立[J]. 中国预防兽医学报, 2019, 41(5): 484-488. |
| [1] | Yuanshuang JIANG,Yang YU,Ruopu LI,Qinyan HUANG,Yunwei SUN,Yan CHEN. Relationship between glucose coefficient of variation and hyperuricemia in early-onset type 2 diabetes mellitus [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 513-522. |
| [2] | Ziru ZHOU,Mengfei SUN,Huakun ZHANG,Shuyan SUN,Qi SUN,Feng LI,Yunzhao CHEN,Jie YU,Yuwen CAO,Xiaobin CUI. Expression of Rh family C glycoprotein in esophageal squamous carcinoma and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 1019-1027. |
| [3] | Mengyao SHAN,Weigang WANG,Jinxiang DONG,Jianming TIAN,Lianlian SONG,Yinghong CHEN,Xiaoxue FANG,Zhidong QIU,Haoming LUO,Difu ZHU. Improvement effect of Panax ginseng glycoproteins on spermatogenesis of mice with oligoasthenozoospermia [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 575-583. |
| [4] | Yinong LIU,Qiang ZHANG,Li XU. Improvement effect of atorvastatin on vascular endothelial dysfunction induced by Ox-LDL/β2GPⅠ/anti-β2GPⅠ complex and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2022, 48(2): 317-323. |
| [5] | Qian MAO, Cuicui CHEN, Huankun LIANG, Penge LIU, Shuhai ZHONG, Laiqing LI. Establishment and evaluation of a double?labeled time? resolved immunofluorescence analysis method for detecting levels of β?CTX and N?MID [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 770-776. |
| [6] | LIU Wei, LUO Xiaohua, CHEN Wenjing, DONG Yuan, ZHU Jie, GUO Jian, JIANG Yong, ZHANG Lei, MENG Guixian, WANG Huiyan. Expression and immunization assessment of HSV-2 glycoprotein D in baculovirus expression vector system [J]. Journal of Jilin University Medicine Edition, 2017, 43(04): 720-724. |
| [7] | LUO Haoming, CHEN Yinghong, ZHOU Tingting, HONG Tie, JIANG Ruizhi, WANG Ying, YANG Xiaohong, MA Li. Influence of glycoprotein from Panax ginsengin study and memory abilities in mice [J]. Journal of Jilin University Medicine Edition, 2016, 42(03): 439-445. |
| [8] | JIANG Hui, ZHANG Tongfei, YANG He, XU Zhaonan, BI Ye, SUN Shu, ZHANG Zebing, JIA Jie. Establishment of human tongue squamous cell carcinoma cisplatin resistant cell line CAL-27/DDPand its biological evaluation [J]. Journal of Jilin University Medicine Edition, 2016, 42(03): 506-511. |
| [9] | LI Jing,LIANG Xiao-fang,ZHAI Gui-lan . Application of combined detection of serum levels of CA199, CA125 and CEA in diagnosis of pancreatic cancer [J]. Journal of Jilin University Medicine Edition, 2014, 40(06): 1252-. |
| [10] | SUN Qin-nuan,LI Dong-mei,YU Hui-ling,MA Hong-xi. Expressions of inflammatory factors in thyroid papillary carcinoma tissue and their clinical significances [J]. Journal of Jilin University Medicine Edition, 2014, 40(06): 1261-1265. |
| [11] | ZHAO Hai-Yan, ZHANG Xiao-Li, GUO Yun, JIANG Li, XIAO Wei-Guo. Determination of a proliferation-inducing ligand |in patients with systemic lupus erythematosus and its clinical significance [J]. J4, 2011, 37(1): 105-108. |
| [12] | ZENG Fei-Yue, WANG Yan-Jin, CHEN Feng-Hua, YANG Zhuan-Yi, DENG Yong-Wen, FANG Jia-Sheng. Expression and significance of MDR1 in human brain |tumor stem cells [J]. J4, 2009, 35(5): 769-773. |
| [13] | FU Jia, TAN Yan, FANG Yan-Qiu, XIONG Bin, XU Li. Preliminary approach on application of recombinant human |2-glycoprotein-1 domain Ⅰ dimer as B lymphocyte tolerogen [J]. J4, 2009, 35(4): 646-649. |
| [14] | YU Fang,HE Bing,QIU Jun,MA Fang-qin, ZHANG Hong. Initial evaluation on safety of herpes simplex virus Ⅰglycoprotein B DNA vaccine in mice [J]. J4, 2008, 34(5): 806-809. |
| [15] | PAN Yu-zhuo, ZHAO Yan-ying, ZHAO Xue-jian, LI Yang. Establishment of multidrug resistance cell line from human prostatic cancinoma [J]. Journal of Jilin University(Medicine Edition), 2007, 33(4): 651-654. |
|